Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
Q2 2021 vs. Q1 2021
How the institutions holding Verona Pharma plc changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 37 | 37 | 0 |
| Shares | 36.5M | 36.7M | +168.7K (+0.5%) |
| Value | $305.1M | $239.9M | −$65.2M (−21.4%) |
New holders (6)
Institutions that held Verona Pharma plc at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock Inc. | 249,941 | $1.64M | 0.00% |
| Chicago Partners Investment Group LLC | 10,006 | $58.0K | 0.00% |
| Bank of America Corp | 3,355 | $22.0K | 0.00% |
| Parallel Advisors, LLC | 2,000 | $13.0K | 0.00% |
| Tower Research Capital LLC (TRC) | 1,365 | $9.00K | 0.00% |
| Deutsche Bank AG | 58 | $0 | 0.00% |
Sold out (6)
Institutions that held Verona Pharma plc at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| HighVista Strategies LLC | 36,638 | $306.0K |
| DAFNA Capital Management LLC | 18,337 | $153.0K |
| Susquehanna International Group, LLP | 15,035 | $126.0K |
| Personal Cfo Solutions, LLC | 10,000 | $84.0K |
| UBS Group AG | 1,407 | $12.0K |
| JPMorgan Chase & Co | 35 | $0 |